🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Clear Cell Carcinoma

The Safety and Efficacy of Allogeneic CD70 CAR-T Therapy in Unresectable or Metastatic Clear Cell Renal Cell Carcinoma NCT07645690EARLY Phase 13 sites📍 Beijing📍 Beijing📍 Beijing Chinese PLA General Hospital · Tests: CLEAR CAR-T cell injection Autologous Dendritic Cell Vaccine in Kidney Cancer NCT05127824Phase 21 site📍 Pittsburgh Jodi Maranchie · Tests: Autologous alpha-DC1/TBVA vaccine, Cabozantinib KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors NCT06026410Phase 138 sites📍 Phoenix📍 Tucson📍 Los Angeles Kura Oncology, Inc. · Tests: Darlifarnib, Cabozantinib, Adagrasib A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) NCT06023862Phase 227 sites📍 Clayton📍 Waratah📍 Melbourne Yonsei University · Tests: Dostarlimab, Bevacizumab, Doxorubicin, Gemcitabine, Paclitaxel An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer NCT06447103Phase 21 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Biospecimen Collection, Bone Scan, Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors NCT04977453Phase 1, Phase 213 sites📍 New York📍 New York📍 Huntersville GI Innovation, Inc. · Tests: GI-101, Pembrolizumab (KEYTRUDA®), Lenvatinib, GI-101A 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT An Open-label, Randomized Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of SLC-3010 and Axitinib Compared to Axitinib Monotherapy as a Second-line Treatment for Locally Advanced or Metastatic Clear Cell Renal Cell Carcinoma NCT07469683Phase 21 site📍 Seoul Yonsei University · Tests: SLC-3010 + Axitinib, Axitinib Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors NCT04777994Phase 130 sites📍 Tucson📍 New Haven📍 Baltimore Calico Life Sciences LLC · Tests: ABBV-CLS-484, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitor (TKI), Programmed Cell Deat… Immunotherapy (Nivolumab and Ipilimumab) With and Without a Live Biotherapeutic Product (EXL01) for the Treatment of Metastatic Renal Cell Cancer NCT07128680Phase 12 sites📍 Duarte📍 Irvine City of Hope Medical Center · Tests: Biospecimen Collection, Bone Scan, Computed Tomography, Faecalibacterium prausnitzii-containing Bacterial Strain Formul… CAIX-targeted PET/CT in Solid Tumors NCT07833085NA1 site📍 Wuhan Zhongnan Hospital · Tests: 68Ga-CAIX Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors NCT05856981Phase 17 sites📍 Detroit📍 St Louis📍 Canton Sairopa B.V. · Tests: ADU-1805, Pembrolizumab Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma NCT07011719Phase 3183 sites📍 Gilbert📍 Goodyear📍 Phoenix Arcus Biosciences, Inc. · Tests: Casdatifan, Cabozantinib, Placebo [18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma NCT04989959Phase 11 site📍 Dallas Orhan Kemal Oz · Tests: [18F]PT2385, Positron Emission Tomography/Computed Tomography, Biopsy IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors NCT05039801Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Bevacizumab, Glutaminase-1 Inhibitor IACS-6274, Paclitaxel, Capivasertib ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer NCT05542407Phase 11 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: Atezolizumab, ONC201 Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma NCT05112601Phase 2138 sites📍 Birmingham📍 Athens📍 Augusta National Cancer Institute (NCI) · Tests: Biospecimen Collection, Computed Tomography, Ipilimumab, Magnetic Resonance Imaging, Nivolumab Study of NTB-928 in R/R OC NCT07690189Phase 14 sites📍 Birmingham📍 Omaha📍 Lake Success TeneoSeven, Inc. · Tests: NTB-928 Safety and Efficacy of Targeting PP2A in Ovarian Clear Cell Carcinoma Using Dostarlimab and LB-100 NCT06065462Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Dostarlimab, LB-100 Efficacy and Safety of the Valemetostat in Patients With Selected Solid Tumors. NCT07303387Phase 24 sites📍 Villejuif📍 Bordeaux📍 Lyon Gustave Roussy, Cancer Campus, Grand Paris · Tests: Valemetostat Tosylate Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma NCT05214885n/a1 site📍 Jinan Qianfoshan Hospital · Tests: No intervention was required for patients or control group in this study REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma NCT07594106Phase 1, Phase 26 sites📍 Goodyear📍 Duarte📍 Tampa Regeneron Pharmaceuticals · Tests: REGN15505, REGN15505+Cemiplimab, REGN15505+REGN4336 A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors NCT03972657Phase 1, Phase 224 sites📍 Gilbert📍 Phoenix📍 Tucson Regeneron Pharmaceuticals · Tests: REGN5678, Cemiplimab Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC) NCT05665361Phase 1, Phase 21 site📍 Bethesda National Cancer Institute (NCI) · Tests: Sasanlimab, Palbocicilib A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy NCT05460000Phase 250 sites📍 Innsbruck📍 Brussels📍 Ghent North Eastern German Society of Gynaecological Oncology · Tests: 3 cycles chemotherapy instead of 6 cycles chemotherapy, 6 cycles chemotherapy CD70-targeted immunoPET Imaging of Kidney Cancer NCT06680089Phase 21 site📍 Shanghai RenJi Hospital · Tests: [18F]RCCB6 Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer NCT07227415Phase 1, Phase 2183 sites📍 Phoenix📍 Scottsdale📍 Fayetteville Pfizer · Tests: PF-08634404, Ipilimumab, Axitinib, Casdatifan Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors NCT05263050Phase 21 site📍 Philadelphia Fox Chase Cancer Center · Tests: Cabozantinib, Nivolumab Assessment of Compliance With Monitoring Conducted by a Physician in Person or by a Nurse in Remote Monitoring NCT05500391Phase 23 sites📍 Amiens📍 Caen📍 Lille Centre Oscar Lambret · Tests: Oncological Follow-up Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC NCT06863311Phase 25 sites📍 La Jolla📍 Indianapolis📍 St Louis Karie Runcie · Tests: XL092, Nivolumab
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy